DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Molecular Imaging Homepage

Generator production for Tc-99m in Australia suspended following mechanical fault Expected to take weeks to repair

James Allison, Padmanee Sharma and Ramy Ibrahim ImaginAb appoints new members to scientific advisory board

Alliance completes deal for Piramal Imaging Expanding market presence in molecular imaging

Siemens announces first global installation of Biograph Vision PET/CT System yields better temporal resolution and sensitivity than previously reported

New PET tracer could help find cure for Alzheimer's Researchers from Yale show they can measure synaptic density: SNMMI

Cardinal Health showcases first integrated cloud solution for nuclear medicine at SNMMI Nuctrac replaces phone and fax orders

Spectrum Dynamics launches 12 detector SPECT system The VERITON SPECT system debuted at SNMMI

GE launched Syntermed's Emory Cardiac Toolbox at SNMMI Affordable option for users with older SPECT systems

Combined radionuclide therapy and immunotherapy shows promise New research unveiled at SNMMI meeting

SNMMI Exhibitor's Guide A few of the companies you'll want to visit with on the show floor

Rat brain 11C-Me-NB1 PET images
superimposed on an MRI template
Courtesy of ETH Zurich

New PET imaging agent may help guide treatment for neurodegenerative diseases

by Lauren Dubinsky , Senior Reporter
Swiss and German researchers have created a new PET imaging agent that may help guide and assess treatments for people with neurological diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis.

“Our new PET radioligand, 11C-Me-NB1, binds to the GluN2B sub-units of the iontropic N-methyl-D-aspartate (NMDA) receptor, for which no suitable PET imaging agent exists despite intensive research,” Simon M. Ametamey of the Institute of Pharmaceutical Sciences, ETH Zurich in Switzerland, told HCB News.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



The NMDA receptor is known to be involved in physiological processes such as learning and memory as well as various acute and chronic neurodegenerative diseases. The availability of 11C-Me-NB1 would allow researchers to study NMDA expression in healthy and diseased human brains and also help with therapy monitoring.

Ametamey and his team conducted a preclinical study that used 1C-Me-NB1 in live rats to investigate the dose and effectiveness of of a drug called eliprodil that blocks the NMDA GluN2B receptor.

The results, which were published recently in The Journal of Nuclear Medicine, demonstrated that the PET scans with the new imaging agent successfully showed that the receptors are fully occupied at neuroprotective doses of eliprodil.

“Administering patients with the right dose of the drugs is essential for minimizing side effects, which are often observed with NMDA drugs when not appropriately dosed,” said Ametamey. “Ultimately this would lead to a reduction in attrition rate and improvement in efficacy of drugs targeting the GluN2B sub-units of the NMDA receptor.”

When asked if 11C-Me-NB1 will eventually become the standard for assessing treatments for patients with neurodegenerative diseases, Ametamey said that it’s difficult to determine, since a clinical study hasn’t been conducted yet.

“Nonetheless, I anticipate that this new imaging agent, even if it doesn’t become the standard, will be used as an imaging tool to complement existing imaging agents used for assessing treatment outcomes for patients with Alzheimer’s, Parkinson’s and MS, among others,” he added.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED